Nasal nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and healthy children

Primary ciliary dyskinesia (PCD) is a rare, inherited disorder characterized by recurrent respiratory tract infections. The measurement of nasal nitric oxide (nNO) is an important test for the diagnosis of PCD. In this study, we aim to evaluate NIOX-MINOÒ, which is an easily applicable method for m...

Full description

Saved in:
Bibliographic Details
Main Authors: Elif Güney, Nagehan Emiralioğlu, Güzin Cinel, Ebru Yalçın, Deniz Doğru, Nural Kiper, Hayriye Uğur Özçelik
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2019-02-01
Series:The Turkish Journal of Pediatrics
Subjects:
Online Access:https://turkjpediatr.org/article/view/646
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850237216499957760
author Elif Güney
Nagehan Emiralioğlu
Güzin Cinel
Ebru Yalçın
Deniz Doğru
Nural Kiper
Hayriye Uğur Özçelik
author_facet Elif Güney
Nagehan Emiralioğlu
Güzin Cinel
Ebru Yalçın
Deniz Doğru
Nural Kiper
Hayriye Uğur Özçelik
author_sort Elif Güney
collection DOAJ
description Primary ciliary dyskinesia (PCD) is a rare, inherited disorder characterized by recurrent respiratory tract infections. The measurement of nasal nitric oxide (nNO) is an important test for the diagnosis of PCD. In this study, we aim to evaluate NIOX-MINOÒ, which is an easily applicable method for measuring nNO, in the diagnosis of patients with PCD and define diagnostic cut-off levels. Furthermore, determining the normal limits of nNO in healthy children and investigating nNO levels of children with cystic fibrosis (CF) are the other aims of this study. The children included in this study were 5 to 18.5 years old, 46 of them had PCD, 44 had CF and 200 were healthy children. To our knowledge, this work contains the widest population compared to previous studies. Subjects receiving steroids or antibiotics or those with any acute respiratory tract infection, asthma or allergic rhinitis were not included in the study. Mean nNO levels were found as 10.4, 22.8 and 21.0 ppb in PCD, CF and healthy children, respectively. The nNO levels for PCD patients were found significantly lower than children with CF and the control groups (p < 0.05). In this study, the diagnostic nNO cut-off level between PCD and the other two groups was determined to be < 11.5 ppb with %83.6 specificity and %67.4 sensitivity. The screening of nNO with NIOX-MINO method provides early diagnose before mucosal biopsy of patients who are suspected to have PCD and therefore, prevents co-morbidities and prolongs survival with early treatment.
format Article
id doaj-art-a361e038e58f46e8b16f246cbea4d185
institution OA Journals
issn 0041-4301
2791-6421
language English
publishDate 2019-02-01
publisher Hacettepe University Institute of Child Health
record_format Article
series The Turkish Journal of Pediatrics
spelling doaj-art-a361e038e58f46e8b16f246cbea4d1852025-08-20T02:01:47ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212019-02-0161110.24953/turkjped.2019.01.004Nasal nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and healthy childrenElif Güney0Nagehan Emiralioğlu1Güzin Cinel2Ebru Yalçın3Deniz Doğru4Nural Kiper5Hayriye Uğur Özçelik6Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.Division of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.Division of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.Division of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.Division of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.Division of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.Division of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Primary ciliary dyskinesia (PCD) is a rare, inherited disorder characterized by recurrent respiratory tract infections. The measurement of nasal nitric oxide (nNO) is an important test for the diagnosis of PCD. In this study, we aim to evaluate NIOX-MINOÒ, which is an easily applicable method for measuring nNO, in the diagnosis of patients with PCD and define diagnostic cut-off levels. Furthermore, determining the normal limits of nNO in healthy children and investigating nNO levels of children with cystic fibrosis (CF) are the other aims of this study. The children included in this study were 5 to 18.5 years old, 46 of them had PCD, 44 had CF and 200 were healthy children. To our knowledge, this work contains the widest population compared to previous studies. Subjects receiving steroids or antibiotics or those with any acute respiratory tract infection, asthma or allergic rhinitis were not included in the study. Mean nNO levels were found as 10.4, 22.8 and 21.0 ppb in PCD, CF and healthy children, respectively. The nNO levels for PCD patients were found significantly lower than children with CF and the control groups (p < 0.05). In this study, the diagnostic nNO cut-off level between PCD and the other two groups was determined to be < 11.5 ppb with %83.6 specificity and %67.4 sensitivity. The screening of nNO with NIOX-MINO method provides early diagnose before mucosal biopsy of patients who are suspected to have PCD and therefore, prevents co-morbidities and prolongs survival with early treatment. https://turkjpediatr.org/article/view/646case control studiescystic fibrosisearly diagnosisnitric oxideprimary ciliary dyskinesia
spellingShingle Elif Güney
Nagehan Emiralioğlu
Güzin Cinel
Ebru Yalçın
Deniz Doğru
Nural Kiper
Hayriye Uğur Özçelik
Nasal nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and healthy children
The Turkish Journal of Pediatrics
case control studies
cystic fibrosis
early diagnosis
nitric oxide
primary ciliary dyskinesia
title Nasal nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and healthy children
title_full Nasal nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and healthy children
title_fullStr Nasal nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and healthy children
title_full_unstemmed Nasal nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and healthy children
title_short Nasal nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and healthy children
title_sort nasal nitric oxide levels in primary ciliary dyskinesia cystic fibrosis and healthy children
topic case control studies
cystic fibrosis
early diagnosis
nitric oxide
primary ciliary dyskinesia
url https://turkjpediatr.org/article/view/646
work_keys_str_mv AT elifguney nasalnitricoxidelevelsinprimaryciliarydyskinesiacysticfibrosisandhealthychildren
AT nagehanemiralioglu nasalnitricoxidelevelsinprimaryciliarydyskinesiacysticfibrosisandhealthychildren
AT guzincinel nasalnitricoxidelevelsinprimaryciliarydyskinesiacysticfibrosisandhealthychildren
AT ebruyalcın nasalnitricoxidelevelsinprimaryciliarydyskinesiacysticfibrosisandhealthychildren
AT denizdogru nasalnitricoxidelevelsinprimaryciliarydyskinesiacysticfibrosisandhealthychildren
AT nuralkiper nasalnitricoxidelevelsinprimaryciliarydyskinesiacysticfibrosisandhealthychildren
AT hayriyeugurozcelik nasalnitricoxidelevelsinprimaryciliarydyskinesiacysticfibrosisandhealthychildren